“We have to have a look at medication on an equivalent level of strategic relevance as weapons,” Badrot claims. Domestic control of the provision chain is vital, he provides.For a number of years, API manufacturing has shaped the biggest share on the pharmaceutical deal manufacturing market place, pushed with the amplified use of generic drugs